XML 17 R26.htm IDEA: XBRL DOCUMENT v2.3.0.15
BASIS OF PRESENTATION OF UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended3 Months Ended
Sep. 30, 2011
Y
Segment
ShareBasedAward
Salon
Sep. 30, 2010
Sep. 30, 2011
2004 Plan
Stock options and SARs
Sep. 30, 2011
2004 Plan
RSAs
Sep. 30, 2011
2004 Plan
RSUs
Sep. 30, 2011
Stock options and SARs
Sep. 30, 2011
SARs
Y
Sep. 30, 2011
RSAs and RSUs
Sep. 30, 2011
RSAs
Y
Jun. 30, 2011
RSAs
Sep. 30, 2011
RSUs
Y
Sep. 30, 2010
Less than
Sep. 30, 2011
Less than
Stock-based compensation award plans             
Number of types of share-based awards granted4            
Award expiration period (in years)  Ten years  Ten years       
Vesting period (in years)  Five yearsFive yearsFive yearsFive years       
Percentage of stock-based awards vesting annually on each of the first five anniversaries of the date of grant (as a percent)  20.00%20.00%         
Compensation expense$ 2.4$ 2.4           
Stock options outstanding             
Balance at the beginning of the period (in shares)838,000            
Forfeited or expired (in shares)(12,000)            
Balance at the end of the period (in shares)826,078            
Exercisable at the end of the period (in shares)663,318            
Stock options, weighted average exercise price             
Balance at the beginning of the period (in dollars per share)$ 31.48            
Forfeited or expired (in dollars per share)$ 26.86            
Balance at the end of the period (in dollars per share)$ 31.54            
Exercisable at the end of the period (in dollars per share)$ 33.27            
Outstanding options, intrinsic value (in dollars)0            
Outstanding options, weighted average remaining contractual term (in years)4.4            
Intrinsic value of exercisable options (in dollars)0            
Weighted average remaining contractual term of exercisable options (in years)3.6            
Options expected to vest (in shares)139,521            
Options expected to vest, weighted average exercise price (in dollars per share)$ 25.29            
Options expected to vest, weighted average remaining contractual life (in years)7.2            
Options expected to vest, total intrinsic value (in dollars)0            
Rollforward of RSAs, RSUs and SARs outstanding             
Nonvested at the beginning of the period (in shares)       1,077,000     
Outstanding at the beginning of the period (in shares)      1,087,000      
Granted (in shares)       20,000     
Vested/Exercised (in shares)       2,000     
Forfeited or expired (in shares)      (57,000)(26,000)     
Outstanding at the end of the period (in shares)      1,029,780 858,415 215,000  
Nonvested at the end of the period (in shares)       1,073,000858,415 215,000  
RSAs, RSUs and SARs outstanding, other relevant terms of the awards             
Weighted Average Grant Date Fair Value, nonvested at the beginning of the period (in dollars per share)       $ 23.48     
Weighted Average Grant Date Fair Value, Granted (in dollars per share)       $ 13.59     
Weighted Average Grant Date Fair Value, Vested/Exercised (in dollars per share)       $ 22.32     
Weighted Average Grant Date Fair Value, Forfeited or Expired (in dollars per share)       $ 19.39     
Weighted Average Grant Date Fair Value, nonvested at the end of the period (in dollars per share)       $ 23.39     
Weighted Average Exercise Price, outstanding at the beginning of the period (in dollars per share)      $ 25.54      
Weighted Average Exercise Price, Forfeited or Expired (in dollars per share)      $ 27.45      
Weighted Average Exercise Price, outstanding at the end of the period (in dollars per share)      $ 25.43      
Exercisable at the end of the period (in shares)      561,530      
Outstanding and unvested awards, intrinsic value      0 12.1 3.0  
Outstanding awards, intrinsic value      0      
Exercisable awards, intrinsic value      0      
Outstanding awards, weighted average remaining contractual term (in years)      6.6 1.9 0.4  
Outstanding and unvested awards expected to vest (in shares)      402,808 806,215    
Outstanding and unvested awards expected to vest, total intrinsic value (in dollars)        11.4    
Outstanding and unvested awards expected to vest, weighted average grant price (in dollars per share)      $ 20.41      
Outstanding and unvested awards expected to vest, remaining contractual term (in years)      7.4      
Unvested RSAs with accelerated vesting period held by the company's chief executive officer and the company's executive vice president (in shares)         68,390   
Incremental compensation cost recognized as a result of the modifications        0.1    
Exercisable awards expected to vest, remaining contractual term (in years)      5.6      
Stock-based compensation award plans, additional disclosures             
Cash received from exercise of share-based instruments0          0.1 
Unrecognized compensation cost related to unvested stock-based compensation17.7            
Period of recognition of unrecognized compensation cost related to unvested stock-based compensation (in years)3.0            
Intrinsic value of share-based awards exercised           $ 0.1$ 0.1